NCT01022476 2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
Clinical Trials
30 trialsNCT02940496 2025-07-15
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01350648 2024-10-01
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
Completed
NCT04540081 2023-12-27
CLOVER
University of California, Davis
Phase NA Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT05498779 2023-11-28
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT04653818 2023-04-04
RCT
Alexandria University
Phase 4 Completed
NCT04980157 2023-01-23
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT02970136 2021-12-28
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Phase NA Completed
NCT03200171 2021-07-21
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
Completed
NCT03707080 2021-07-06
Direct Acting Antiviral-Post Authorization Safety Study
Target PharmaSolutions, Inc.
Completed
NCT03706742 2021-04-20
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
University of Texas Southwestern Medical Center
Phase NA Completed
NCT03254121 2021-02-18
HEPCASUS
Karolinska Institutet
Completed
NCT00341705 2019-12-17
The Second Multicenter Hemophilia Cohort Study
National Institutes of Health Clinical Center (CC)
Completed
NCT00825877 2019-12-17
Long-term Follow-up of HALT-C Sustained Virological Responders
National Institutes of Health Clinical Center (CC)
Completed
NCT01619475 2019-02-08
A2ALL-2
Arbor Research Collaborative for Health
Completed
NCT02833298 2018-10-12
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT00513461 2018-08-10
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
Phase 2 Completed
NCT00096733 2017-08-29
A2ALL-1
Arbor Research Collaborative for Health
Completed
NCT03197155 2017-06-23
RECAR
Hospices Civils de Lyon
Completed
NCT01804829 2017-03-15
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
Phase 3 Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT01559844 2016-07-27
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Gilead Sciences
Phase 2 Completed
NCT02113865 2015-03-09
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Completed
NCT01405183 2014-09-17
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Henry Ford Health System
Completed
NCT01355107 2011-12-14
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease
University Hospital Freiburg
Completed
NCT00273247 2006-01-09
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
National Cancer Institute, Milan
Phase 3 Completed